Biofarm S.A. (BVB:BIO)

Market Cap	717.35M
Revenue (ttm)	310.33M
Net Income (ttm)	86.10M
Shares Out	985.37M
EPS (ttm)	0.08
PE Ratio	9.17
Forward PE	n/a
Dividend	0.03 (4.26%)
Ex-Dividend Date	Aug 18, 2025

Volume	144,679
Average Volume	86,219
Open	0.7280
Previous Close	0.7280
Day's Range	0.7120 - 0.7280
52-Week Range	0.6200 - 0.8120
Beta	0.31
RSI	62.42
Earnings Date	Aug 14, 2025

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 373
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.